{2 (355 ML) (magnesium sulfate 0.0277 MEQ/ML / potassium sulfate 0.0374 MEQ/ML / sodium sulfate 0.257 MEQ/ML Oral Solution) } Pack
- RxCUI
- 2390767
- RxNorm name
- {2 (355 ML) (magnesium sulfate 0.0277 MEQ/ML / potassium sulfate 0.0374 MEQ/ML / sodium sulfate 0.257 MEQ/ML Oral Solution) } Pack
- Display name
- {2 (355 ML) (magnesium sulfate 0.0277 MEQ/ML / potassium sulfate 0.0374 MEQ/ML / sodium sulfate 0.257 MEQ/ML Oral Solution) } Pack
- Full name
- {2 (355 ML) (magnesium sulfate 0.0277 MEQ/ML / potassium sulfate 0.0374 MEQ/ML / sodium sulfate 0.257 MEQ/ML Oral Solution) } Pack
- Term type
- GPCK
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:38:52
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| SODIUM SULFATE, POTASSIUM SULFATE AND MAGNESIUM SULFATE | SODIUM SULFATE, POTASSIUM SULFATE, MAGNESIUM SULFATE | Wilshire Pharmaceuticals, Inc. | f269929e-c2ff-4288-9d3b-7770bcb5a498 | 2026-04-13 | Warnings, Adverse reactions | 2390767 |
| SUPREP Bowel Prep | SODIUM SULFATE, POTASSIUM SULFATE, MAGNESIUM SULFATE | Azurity Pharmaceuticals, Inc. | 50f23abd-6a66-44cb-960e-d43c16a5ae5f | 2026-01-31 | Warnings, Adverse reactions | 2390767 |
| SODIUM SULFATE, POTASSIUM SULFATE AND MAGNESIUM SULFATE | SODIUM SULFATE, POTASSIUM SULFATE, MAGNESIUM SULFATE | Affordable Pharmaceuticals, LLC | f86bdcc8-e643-4160-89ae-01c89bee842d | 2025-11-30 | Warnings, Adverse reactions | 2390767 |
| SUPREP Bowel Prep | SODIUM SULFATE, POTASSIUM SULFATE, MAGNESIUM SULFATE | Braintree Laboratories, Inc. | 2f5f06de-ee98-44c0-be7e-9a998d1e5c16 | 2025-11-30 | Warnings, Adverse reactions | 2390767 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm string | TTY | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 2f5f06de-ee98-44c0-be7e-9a998d1e5c16 | {2 (355 ML) (magnesium sulfate 0.0277 MEQ/ML / potassium sulfate 0.0374 MEQ/ML / sodium sulfate 0.257 MEQ/ML Oral Solution) } Pack | GPCK | 9 | These highlights do not include all the information needed to use SUPREP BOWEL PREP KIT safely and effectively. See full prescribing information for SUPREP BOWEL PREP KIT. SUPREP BOWEL PREP KIT (sodium sulfate, potassium sulfate, and magnesium sulfate) oral solution Initial U.S. Approval: 2010 | 20251130 |
| 2f5f06de-ee98-44c0-be7e-9a998d1e5c16 | {2 (12 OZ magnesium sulfate 1.2 GM / potassium sulfate 2.35 GM / sodium sulfate 13.13 GM Oral Solution) } Pack | PSN | 9 | These highlights do not include all the information needed to use SUPREP BOWEL PREP KIT safely and effectively. See full prescribing information for SUPREP BOWEL PREP KIT. SUPREP BOWEL PREP KIT (sodium sulfate, potassium sulfate, and magnesium sulfate) oral solution Initial U.S. Approval: 2010 | 20251130 |
| f86bdcc8-e643-4160-89ae-01c89bee842d | {2 (12 OZ magnesium sulfate 1.2 GM / potassium sulfate 2.35 GM / sodium sulfate 13.13 GM Oral Solution) } Pack | PSN | 2 | These highlights do not include all the information needed to use SODIUM SULFATE, POTASSIUM SULFATE AND MAGNESIUM SULFATE ORAL SOLUTION safely and effectively. See full prescribing information for SODIUM SULFATE, POTASSIUM SULFATE AND MAGNESIUM SULFATE ORAL SOLUTION SODIUM SULFATE, POTASSIUM SULFATE AND MAGNESIUM SULFATE ORAL SOLUTION Initial U.S. Approval: 2010 | 20251130 |
| f86bdcc8-e643-4160-89ae-01c89bee842d | {2 (355 ML) (magnesium sulfate 0.0277 MEQ/ML / potassium sulfate 0.0374 MEQ/ML / sodium sulfate 0.257 MEQ/ML Oral Solution) } Pack | GPCK | 2 | These highlights do not include all the information needed to use SODIUM SULFATE, POTASSIUM SULFATE AND MAGNESIUM SULFATE ORAL SOLUTION safely and effectively. See full prescribing information for SODIUM SULFATE, POTASSIUM SULFATE AND MAGNESIUM SULFATE ORAL SOLUTION SODIUM SULFATE, POTASSIUM SULFATE AND MAGNESIUM SULFATE ORAL SOLUTION Initial U.S. Approval: 2010 | 20251130 |
| f269929e-c2ff-4288-9d3b-7770bcb5a498 | {2 (355 ML) (magnesium sulfate 0.0277 MEQ/ML / potassium sulfate 0.0374 MEQ/ML / sodium sulfate 0.257 MEQ/ML Oral Solution) } Pack | GPCK | 1 | These highlights do not include all the information needed to use SODIUM SULFATE, POTASSIUM SULFATE AND MAGNESIUM SULFATE ORAL SOLUTION safely and effectively. See full prescribing information for SODIUM SULFATE, POTASSIUM SULFATE AND MAGNESIUM SULFATE ORAL SOLUTION. SODIUM SULFATE, POTASSIUM SULFATE AND MAGNESIUM SULFATE ORAL SOLUTION Initial U.S. Approval: 2010 | 20260413 |
| f269929e-c2ff-4288-9d3b-7770bcb5a498 | {2 (12 OZ magnesium sulfate 1.2 GM / potassium sulfate 2.35 GM / sodium sulfate 13.13 GM Oral Solution) } Pack | PSN | 1 | These highlights do not include all the information needed to use SODIUM SULFATE, POTASSIUM SULFATE AND MAGNESIUM SULFATE ORAL SOLUTION safely and effectively. See full prescribing information for SODIUM SULFATE, POTASSIUM SULFATE AND MAGNESIUM SULFATE ORAL SOLUTION. SODIUM SULFATE, POTASSIUM SULFATE AND MAGNESIUM SULFATE ORAL SOLUTION Initial U.S. Approval: 2010 | 20260413 |
| 50f23abd-6a66-44cb-960e-d43c16a5ae5f | {2 (12 OZ magnesium sulfate 1.2 GM / potassium sulfate 2.35 GM / sodium sulfate 13.13 GM Oral Solution) } Pack | PSN | 1 | These highlights do not include all the information needed to use SUPREP BOWEL PREP KIT safely and effectively. See full prescribing information for SUPREP BOWEL PREP KIT. SUPREP BOWEL PREP KIT (sodium sulfate, potassium sulfate, and magnesium sulfate) oral solution Initial U.S. Approval: 2010 | 20260131 |
| 50f23abd-6a66-44cb-960e-d43c16a5ae5f | {2 (355 ML) (magnesium sulfate 0.0277 MEQ/ML / potassium sulfate 0.0374 MEQ/ML / sodium sulfate 0.257 MEQ/ML Oral Solution) } Pack | GPCK | 1 | These highlights do not include all the information needed to use SUPREP BOWEL PREP KIT safely and effectively. See full prescribing information for SUPREP BOWEL PREP KIT. SUPREP BOWEL PREP KIT (sodium sulfate, potassium sulfate, and magnesium sulfate) oral solution Initial U.S. Approval: 2010 | 20260131 |